Cas no 2208-59-5 (2-(pyridin-4-yl)-1H-1,3-benzodiazole)
2-(pyridin-4-yl)-1H-1,3-benzodiazole Chemical and Physical Properties
Names and Identifiers
-
- 2-(Pyridin-4-yl)-1H-benzo[d]imidazole
- 2-(4-Pyridyl)benzimidazole
- 1H-Benzimidazole,2-(4-pyridinyl)-
- 2-(4-pyridinyl)-1H-Benzimidazole
- 2-pyridin-4-yl-1H-benzimidazole
- 2-Pyridin-4-yl-1H-benzoimidazole
- 2-(pyridin-4-yl)-1h-benzimidazole
- 2-(pyridin-4-yl)-1H-1,3-benzodiazole
- MLS000736695
- MLS000709114
- 2-(4-pyridyl)-1H-benzimidazole
- UYWWLYCGNNCLKE-UHFFFAOYSA-N
- SMR000282981
- NSC62609
- Cambridge id 5231114
- NCIOpen2_000009
- Oprea1_792619
- Oprea1_021863
- cid_247634
- 2-(4-pyridinyl)-benzimidazole
- BDBM557
- P1658
- F0191-4540
- YSWG076
- AKOS000275319
- 2H-Benzimidazole,2-(4(1H)-pyridinylidene)-(9CI)
- SCHEMBL695990
- Benzimidazole, 2-(4-pyridinyl)-
- EN300-16229
- AS-63158
- BB 0219594
- FT-0740218
- Z50129789
- NSC-62609
- SY051172
- SR-01000391502-1
- 2-Benzimidazole
- SR-01000391502
- 2-(4-Pyridinyl)-1H-benzimidazole #
- 2-(Pyridin-4(1H)-ylidene)-2H-benzo[d]imidazole
- 176964-61-7
- HMS2691B22
- BDBM55759
- CHEMBL379376
- D92142
- MFCD00453948
- AE-848/30862035
- 2208-59-5
- DTXSID80289654
- CS-0073067
- DB-270266
- 2H-BENZIMIDAZOLE, 2-(4(1H)-PYRIDINYLIDENE)-
- STK727086
- DA-20879
- 1H-Benzimidazole, 2-(4-pyridinyl)-
- ALBB-017633
-
- MDL: MFCD00453948
- Inchi: 1S/C12H9N3/c1-2-4-11-10(3-1)14-12(15-11)9-5-7-13-8-6-9/h1-8H,(H,14,15)
- InChI Key: UYWWLYCGNNCLKE-UHFFFAOYSA-N
- SMILES: N1C(C2C=CN=CC=2)=NC2C=CC=CC1=2
Computed Properties
- Exact Mass: 195.08000
- Monoisotopic Mass: 195.08
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 15
- Rotatable Bond Count: 1
- Complexity: 213
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: 2
- XLogP3: 2.2
- Topological Polar Surface Area: 41.6
Experimental Properties
- Color/Form: Not determined
- Density: 1.27
- Melting Point: 216.0 to 220.0 deg-C
- Boiling Point: 438.1°Cat760mmHg
- Flash Point: 212.2°C
- Refractive Index: 1.699
- PSA: 41.57000
- LogP: 2.62490
- Solubility: Not determined
2-(pyridin-4-yl)-1H-1,3-benzodiazole Security Information
-
Symbol:
- Prompt:warning
- Hazard Statement: H315-H319
- Warning Statement: P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313
2-(pyridin-4-yl)-1H-1,3-benzodiazole Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
2-(pyridin-4-yl)-1H-1,3-benzodiazole Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd. | P1658-1G |
2-(4-Pyridyl)benzimidazole |
2208-59-5 | >98.0%(HPLC) | 1g |
¥690.00 | 2024-04-17 | |
| Fluorochem | 070115-2.5g |
2-Pyridin-4-yl-1H-benzimidazole |
2208-59-5 | 98% | 2.5g |
£58.00 | 2022-03-01 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | P160620-1G |
2-(pyridin-4-yl)-1H-1,3-benzodiazole |
2208-59-5 | >96.0%(HPLC) | 1g |
¥182.90 | 2023-09-01 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | P160620-200mg |
2-(pyridin-4-yl)-1H-1,3-benzodiazole |
2208-59-5 | >96.0%(HPLC) | 200mg |
¥102.90 | 2023-09-01 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | P160620-25g |
2-(pyridin-4-yl)-1H-1,3-benzodiazole |
2208-59-5 | >96.0%(HPLC) | 25g |
¥1803.90 | 2023-09-01 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | P160620-5G |
2-(pyridin-4-yl)-1H-1,3-benzodiazole |
2208-59-5 | >96.0%(HPLC) | 5g |
¥449.90 | 2023-09-01 | |
| Alichem | A029185044-1g |
2-(Pyridin-4-yl)-1H-benzo[d]imidazole |
2208-59-5 | 95% | 1g |
$151.84 | 2023-09-02 | |
| Chemenu | CM162063-5g |
2-Pyridin-4-yl-1H-benzimidazole |
2208-59-5 | 95% | 5g |
$504 | 2021-08-05 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | P866907-5g |
2-(4-Pyridyl)benzimidazole |
2208-59-5 | ≥98% | 5g |
1,089.00 | 2021-05-17 | |
| TRC | P840598-10mg |
2-(4-Pyridyl)benzimidazole |
2208-59-5 | 10mg |
$ 50.00 | 2022-06-03 |
2-(pyridin-4-yl)-1H-1,3-benzodiazole Related Literature
-
Em Canh Pham,Tuong Vi Le Thi,Huong Ha Ly Hong,Bich Ngoc Vo Thi,Long B. Vong,Thao Thanh Vu,Duy Duc Vo,Ngoc Vi Tran Nguyen,Khanh Nguyen Bao Le,Tuyen Ngoc Truong RSC Adv. 2023 13 399
-
2. Experimental and theoretical approving of anomeric based oxidation in the preparation of 2-sbstituted benz-(imida, oxa and othia)-zoles using [2,6-DMPy-NO2]C(NO2)3 as a novel nano molten salt catalystMohammad Ali Zolfigol,Ardeshir Khazaei,Saied Alaie,Saeed Baghery,Farahnaz Maleki,Yadollah Bayat,Asiye Asgari RSC Adv. 2016 6 58667
-
Mudzuli Maphupha,Wanyama P. Juma,Charles B. de Koning,Dean Brady RSC Adv. 2018 8 39496
-
Xin Zhang,Zhong-Jie Wang,Shu-Guang Chen,Zhen-Zhen Shi,Jin-Xi Chen,He-Gen Zheng Dalton Trans. 2017 46 2332
-
Chun-Rong Ye,Ji Zheng,Mian Li,Xiao-Chun Huang Chem. Commun. 2018 54 8769
Additional information on 2-(pyridin-4-yl)-1H-1,3-benzodiazole
Comprehensive Overview of 2-(Pyridin-4-yl)-1H-1,3-benzodiazole (CAS No. 2208-59-5): Properties, Applications, and Research Insights
2-(Pyridin-4-yl)-1H-1,3-benzodiazole, identified by its CAS number 2208-59-5, is a heterocyclic compound that has garnered significant attention in pharmaceutical and materials science research. This compound, often referred to as a pyridine-benzodiazole derivative, exhibits unique structural features that make it valuable for diverse applications, including drug development, organic electronics, and fluorescence-based sensors. Its molecular framework combines a pyridine ring with a benzodiazole moiety, offering tunable electronic properties and binding affinities.
In recent years, the demand for heterocyclic compounds like 2-(pyridin-4-yl)-1H-1,3-benzodiazole has surged due to their role in designing small-molecule inhibitors and photovoltaic materials. Researchers are particularly interested in its potential as a fluorescent probe for biological imaging, leveraging its stable emission characteristics. Additionally, its ligand properties make it a candidate for metal-organic frameworks (MOFs), a trending topic in nanotechnology and sustainable chemistry.
The synthesis of CAS 2208-59-5 typically involves condensation reactions between 4-pyridinecarboxaldehyde and o-phenylenediamine, followed by oxidative cyclization. This process highlights the compound's adaptability for scalable production, a key consideration for industrial applications. Analytical techniques such as NMR spectroscopy and mass spectrometry are employed to confirm its purity, which is critical for reproducibility in research.
From a pharmacological perspective, 2-(pyridin-4-yl)-1H-1,3-benzodiazole has been explored for its kinase inhibitory activity, aligning with the growing interest in targeted cancer therapies. Its ability to modulate protein-protein interactions also positions it as a promising scaffold for neurodegenerative disease research, a hot topic in 2024 due to rising global health concerns.
Environmental and safety profiles of 2208-59-5 are equally important. Studies indicate low acute toxicity, but proper handling protocols are recommended to avoid inhalation or skin contact. Its stability under ambient conditions makes it suitable for long-term storage, a practical advantage for laboratories.
In summary, 2-(pyridin-4-yl)-1H-1,3-benzodiazole (CAS 2208-59-5) represents a versatile compound bridging multiple scientific disciplines. Its applications span from biomedical research to advanced materials, reflecting the compound's adaptability to cutting-edge innovations. As interdisciplinary research grows, this compound is poised to play a pivotal role in addressing contemporary scientific challenges.
2208-59-5 (2-(pyridin-4-yl)-1H-1,3-benzodiazole) Related Products
- 84123-77-3(6-methyl-2-(4-pyridinyl)-1H-Benzimidazole)
- 914296-27-8(2-phenyl-5H-imidazo4,5-cpyridine)
- 7118-66-3(1H-Benzimidazole, 5-methyl-2-(4-methylphenyl)-)
- 63411-79-0(3H-Imidazo[4,5-c]pyridine,2-(4-pyridinyl)-)
- 176964-61-7(2H-Benzimidazole,2-(4(1H)-pyridinylidene)-)
- 89074-96-4(1H-Imidazo[4,5-c]pyridine, 2-(3-methylphenyl)-)
- 2963-65-7(6-methyl-2-phenyl-1H-1,3-benzodiazole)
- 75007-92-0(2-phenyl-5H-imidazo4,5-cpyridine)
- 78541-56-7(2-pyridin-4-yl-1h-imidazo[4,5-f][1,8]phenanthroline)
- 89075-52-5(1H-Imidazo[4,5-c]pyridine, 2-(4-methylphenyl)-)